Trends in Drug Discovery & Development: March 2019
Expert interviews on a novel target for glioblastoma, new approach to Alzheimer’s disease therapy, mapping tumors at the molecular level and more
Expert interviews on a novel target for glioblastoma, new approach to Alzheimer’s disease therapy, mapping tumors at the molecular level and more
Nobel Prize winner, INTEGRA Biosciences, a hurricane hero and WITec among those recognized at SelectScience's celebration in Philadelphia
The first Gold Seal of Quality of the year among the new awards presented to the world’s top-rated laboratory products
Visit booth 4115 for the latest analytical technologies for characterizing biomolecular signatures of cancer
Learn how innovative mass spectrometry techniques are enabling scientists to explore the molecular make-up of tumors — opening the way to better drug efficacy and new treatment strategies
Opening up conversation to advance cannabis science
The highly reliable offering from Shimadzu delivers stable data acquisition, low running cost and high efficiency
Introducing BMG LABTECH’s new microplate reader and troubleshooting tips to help you improve assay development and save vital time
Don’t miss out on the most exciting stories unfolding in the Drug Discovery & Development Community
Learn about the benefits of the Method Lifecycle Management approach and how to implement this approach in your lab
We take a look at some of the latest methods and technologies disrupting drug discovery and how they’re reshaping the industry
Gilson Connect and SciNote aim to overcome the lack of reproducibility across scientific articles
Beckman Coulter Life Sciences has announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California
Learn how inert-glass vials can secure your sophisticated ultra-trace analysis